New method for diagnosing esophageal cancer in low-income countries
Official title: Point-of-Care Diagnosis of Esophageal Cancer in LMICs
Funded at Johns Hopkins University · NIH-10843258 · Data updated 2026-11-12
This study is testing a simple and affordable way to help find esophageal cancer early by using a swallowable sponge that collects samples, making it easier for people in low- and middle-income countries to get checked without needing fancy equipment or special training.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $576,573 |
| NIH project number | 5U01CA279866-02 |
| Project ID | NIH-10843258 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living in low- and middle-income countries who are at high risk for esophageal cancer.
✕Less likely to help
Patients with esophageal cancer who are already diagnosed and receiving treatment may not benefit from this research.
What this research studies
This research aims to develop a cost-effective and non-invasive method for diagnosing esophageal cancer, particularly squamous cell carcinoma, in low- and middle-income countries (LMICs). It utilizes a swallowable sponge device that collects esophageal samples, which are then analyzed using a portable magnetofluidic chip for DNA methylation markers. This approach is designed to be performed in remote areas without the need for extensive medical training or advanced equipment, making it accessible for high-risk patients. By improving early detection, the research seeks to enhance treatment options and outcomes for patients in these regions.
Why it matters
Potential benefit: If successful, this research could significantly improve early detection and treatment of esophageal cancer in underserved populations.
How similar studies have gone: Other research has shown promise in using innovative diagnostic methods for cancer detection in resource-limited settings, indicating potential success for this approach.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Meltzer, Stephen J — Johns Hopkins University
- Study coordinator: Meltzer, Stephen J
Related research
Other NIH-funded projects on the same topics.
-
AI-guided microendoscopy to detect esophageal cancer早期
A doctor-research team is testing an AI-assisted microendoscopy tool to screen people at risk for esophageal cancer, aiming to find cancer early with higher accuracy and fewer unnecessary biopsies.
-
AI-assisted Microendoscopy to Detect Esophageal Cancer Earlier
A technology-based approach uses AI and a tiny endoscopy device to screen for early esophageal cancer, focusing on high-risk regions around the world.</n>
-
Point-of-care esophageal cancer detection in low- and middle-income countries
A researcher-led effort to use a swallowable sponge and a portable chip to detect DNA methylation markers of esophageal cancer right where patients live, helping people in LMICs get quick results.
-
AI-assisted Microendoscopy for early esophageal cancer detection
A Baylor College of Medicine team is testing a mobile, AI-driven microscopic imaging tool to help screen for early esophageal cancer in regions with limited screening capacity.
-
OmicXScreen: AI-powered blood test to detect liver and esophageal cancers early
A new blood test using AI and DNA methylation patterns aims to detect hepatocellular carcinoma and esophageal cancer early, helping people who are at high risk.
-
AI-assisted microendoscopy to find esophageal cancer early
This project uses a small, high-resolution endoscope plus AI to help doctors spot early esophageal cancer in people at risk, especially where screening is limited.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.